About Esperante
Esperante is a Financial Services company based in Hoofddorp (Netherlands). Esperante is focused on innovative life science investments. It operates on a Professional Services model in Financial Services and Healthcare sectors. Esperante offers products and services including Life Science Investments. Its focus areas include Finance, Investment Management, Venture Capital and Biotechnology.
Company details
Esperante is engaged as a corporate venture investment company, specializing in mid to late-stage clinical therapeutics development firms across North America and Europe. Investments are made in sectors such as endocrinology, hepatology, ophthalmology, oncology, and urology. The company is part of CP Investors Group, involved in diagnostics, pharmaceuticals, and peptide-based solutions.
- Headquarters Hoofddorp, Netherlands
- SectorsFinancial ServicesHealthcare
- Email••••••••
- Website esperante.com
- Social LinkedIn
Products & Services of Esperante
Esperante offers a comprehensive portfolio of products and services, including Life Science Investments.
Investments are made in life science therapeutic companies.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Esperante
Esperante is headquartered in Hoofddorp, Netherlands. It is registered at Hoofddorp, North Holland, Netherlands.
Esperante is engaged as a corporate venture investment company, specializing in mid to late-stage clinical therapeutics development firms across North America and Europe. Investments are made in sectors such as endocrinology, hepatology, ophthalmology, oncology, and urology. The company is part of CP Investors Group, involved in diagnostics, pharmaceuticals, and peptide-based solutions.
Esperante offers Life Science Investments.